Neuropeptides Generate Tolerogenic Dendritic Cells for Treating Autoimmune Disease
Neuropeptides (VIP, PACAP, alpha-MSH) generate tolerogenic dendritic cells that suppress autoimmune responses through Treg induction — a practical immunotherapy approach using the neuroimmune system.
Quick Facts
What This Study Found
Neuropeptides (VIP, PACAP, alpha-MSH) generate tolerogenic dendritic cells that suppress autoimmune responses through Treg induction — a practical immunotherapy approach using the neuroimmune system.
Key Numbers
How They Did This
research study.
Why This Research Matters
Relevant for peptide research.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
Trust & Context
- Key Stat:
- Key finding Neuropeptides (VIP, PACAP, alpha-MSH) generate tolerogenic dendritic cells that suppress autoimmune responses through Treg induction — a practical imm
- Evidence Grade:
- emerging evidence.
- Study Age:
- Published in 2009.
- Original Title:
- Generating tolerogenic dendritic cells with neuropeptides.
- Published In:
- Human immunology, 70(5), 300-7 (2009)
- Authors:
- Delgado, Mario(10)
- Database ID:
- RPEP-01471
Evidence Hierarchy
Frequently Asked Questions
What was studied?
Neuropeptides Generate Tolerogenic Dendritic Cells for Treating Autoimmune Disease
What was found?
Neuropeptides (VIP, PACAP, alpha-MSH) generate tolerogenic dendritic cells that suppress autoimmune responses through Treg induction — a practical immunotherapy approach using the neuroimmune system.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01471APA
Delgado, Mario. (2009). Generating tolerogenic dendritic cells with neuropeptides.. Human immunology, 70(5), 300-7.
MLA
Delgado, Mario. "Generating tolerogenic dendritic cells with neuropeptides.." Human immunology, 2009.
RethinkPeptides
RethinkPeptides Research Database. "Generating tolerogenic dendritic cells with neuropeptides." RPEP-01471. Retrieved from https://rethinkpeptides.com/research/delgado-2009-generating-tolerogenic-dendritic-cells
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.